STANDARD BIOTOOLS INC LAB 5.25 12.01.24
NOTE 5.250%12/0 · US DOMESTIC · CUSIP 34385PAF5
5
institutional holders
-1 vs Q1 2023
$55.0mprincipal reported held*
$57.9mreported value*
0 new
1 added
0 reduced
1 sold out
net bought ≈ $0
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once ($2.9m this quarter). Holder counts are more reliable.
Trends to Q2 2023
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 6 |
| Q4 2022 | 6 |
| Q1 2023 | 6 |
| Q2 2023 | 5 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 0 | 1 |
| Q1 2023 | 0 | 1 |
| Q2 2023 | 1 | 1 |
Biggest buyers
| Indaba Capital Management, L.P. | Added | +7.8m |
Biggest sellers
| ROYAL BANK OF CANADA | Sold out | -7.8m |
Holders, Q2 2023
| Manager | Shares | Change |
|---|---|---|
| Indaba Capital Management, L.P. 14.41% of their portfolio | 40.5m $42.6m | Added +7.8m |
| DeepCurrents Investment Group LLC 0.44% of their portfolio | 9.5m $10.1m | Unchanged |
| SILVERBACK ASSET MANAGEMENT LLC 0.71% of their portfolio | 5.0m $5.2m | Unchanged |
| Verition Fund Management LLC 0.05% of their portfolio | 2.8k $2.9m | Unchanged |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |